Clinical Trials Logo

Lipid Metabolism, Inborn Errors clinical trials

View clinical trials related to Lipid Metabolism, Inborn Errors.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03393130 Not yet recruiting - Critical Illness Clinical Trials

Perioperative Research Into Memory, Genomics in the Intensive Therapy Unit: Alzheimer's

PRIMoGenITA
Start date: February 1, 2018
Phase: N/A
Study type: Observational

The current central dogma of long-term cognitive impairment after intensive care admission suggests an underlying neuroinflammatory dysregulation affecting neuronal function. This pathological process has not been fully elucidated and there has been little research into its genetic associations. Alzheimer's disease (AD) causes cognitive impairment through a process of abnormal beta amyloid deposition and neuronal death through localised activation of the innate immune system. It is the most prevalent disease affecting cognition. The Apolipoprotein E (APOE) gene is implicated in the progression of late-onset Alzheimer's disease and is a recognised neuroinflammatory modulator. It is possible that young individuals exposed to high levels of inflammation may experience an acceleration of this process. This study sets out to look for an association between APOE-∈4 possession and poor cognitive outcome after a major burn injury and intensive care admission.

NCT ID: NCT02707211 Not yet recruiting - Clinical trials for Lipid Metabolism, Inborn Errors

Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases

Start date: June 2016
Phase: Phase 0
Study type: Interventional

To test whether active pneumococci immunization can alleviate inflammation and improve cholesterol metabolism in lysosomal lipid storage diseases and associated metabolic disorders.